Hikal (NSEI:HIKAL) - Cotización, noticias y análisis

Resumen de acción HIKAL

HIKAL fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	4/6
Past Performance	3/6
Financial Health	5/6
Dividends	4/6

Recompensas

Se prevé un crecimiento anual de los beneficios de 50.42%

Análisis de riesgos

Historial de dividendos inestable

Tiene un alto nivel de endeudamiento

Competidores de Hikal Limited

Supriya Lifescience

NSEI:SUPRIYA

₹29.3b

Gufic Biosciences

BSE:509079

₹29.7b

Indoco Remedies

NSEI:INDOCO

₹30.5b

Aarti Drugs

BSE:524348

₹45.6b

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Hikal
Historical stock prices
Current Share Price	₹319.90
52 Week High	₹329.00
52 Week Low	₹250.10
Beta	1.14
1 Month Change	15.59%
3 Month Change	11.81%
1 Year Change	8.79%
3 Year Change	46.64%
5 Year Change	76.79%
Change since IPO	2,101.15%

Noticias y actualizaciones recientes

Recent updates

Increases to CEO Compensation Might Be Put On Hold For Now at Hikal Limited (NSE:HIKAL)

Sep 16

Calculating The Fair Value Of Hikal Limited (NSE:HIKAL)

Mar 18

Hikal (NSE:HIKAL) Is Increasing Its Dividend To ₹1.20

Feb 16

Is Hikal (NSE:HIKAL) Using Too Much Debt?

Jan 13

With EPS Growth And More, Hikal (NSE:HIKAL) Is Interesting

Jun 01

We Think Hikal (NSE:HIKAL) Can Stay On Top Of Its Debt

May 17

An Intrinsic Calculation For Hikal Limited (NSE:HIKAL) Suggests It's 25% Undervalued

Mar 23

Does Hikal Limited (NSE:HIKAL) Have A Place In Your Dividend Portfolio?

Mar 10

If You Like EPS Growth Then Check Out Hikal (NSE:HIKAL) Before It's Too Late

Feb 23

Be Sure To Check Out Hikal Limited (NSE:HIKAL) Before It Goes Ex-Dividend

Feb 10

Is Hikal Limited's (NSE:HIKAL) Recent Stock Performance Influenced By Its Financials In Any Way?

Feb 05

Is Hikal Limited's (NSE:HIKAL) Shareholder Ownership Skewed Towards Insiders?

Jan 22

Update: Hikal (NSE:HIKAL) Stock Gained 53% In The Last Five Years

Jan 03

Is Hikal (NSE:HIKAL) A Risky Investment?

Dec 13

Why Hikal Limited (NSE:HIKAL) Is A Dividend Rockstar

Nov 22

Should Weakness in Hikal Limited's (NSE:HIKAL) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Nov 01

Here's What Hikal Limited's (NSE:HIKAL) Shareholder Ownership Structure Looks Like

Oct 11

Hikal (NSE:HIKAL) Shareholders Have Enjoyed An Impressive 162% Share Price Gain

Sep 20

Hikal Limited (NSE:HIKAL) Passed Our Checks, And It's About To Pay A ₹0.20 Dividend

Sep 02

Why Hikal Limited (NSE:HIKAL) Is A Dividend Rockstar

Aug 23

Hikal Limited's (NSE:HIKAL) Share Price Matching Investor Opinion

Aug 03

Rentabilidad de los accionistas

	HIKAL	IN Pharmaceuticals	Mercado IN
7D	6.4%	-1.4%	-1.6%
1Y	8.8%	53.7%	45.0%

Rentabilidad vs. Industria: HIKAL obtuvo unos resultados inferiores a los del sector Indian Pharmaceuticals , que el año pasado arrojó un rendimiento del 65.4%.

Rentabilidad vs. Mercado: HIKAL obtuvo unos resultados inferiores a los del mercado Indian, que fue del 44.7% el año pasado.

Volatilidad de los precios

Is HIKAL's price volatile compared to industry and market?
HIKAL volatility
HIKAL Average Weekly Movement	4.0%
Pharmaceuticals Industry Average Movement	6.0%
Market Average Movement	6.9%
10% most volatile stocks in IN Market	10.1%
10% least volatile stocks in IN Market	4.2%

Precio estable de las acciones: HIKAL no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de HIKAL (4%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
1988	2,142	Sameer Hiremath	www.hikal.com

Hikal Limited, junto con sus filiales, fabrica y vende diversos productos químicos intermedios, especialidades químicas e ingredientes farmacéuticos activos a empresas farmacéuticas, de salud animal, biotecnología, protección de cultivos y especialidades químicas de la India. La empresa opera a través de dos segmentos: productos farmacéuticos y protección de cultivos. El segmento farmacéutico produce ingredientes farmacéuticos activos (API).

Resumen de fundamentos de Hikal Limited

¿Cómo se comparan los beneficios e ingresos de Hikal con su capitalización de mercado?
Estadísticas fundamentales de HIKAL
Capitalización bursátil	₹36.83b
Beneficios(TTM)	₹716.22m
Ingresos (TTM)	₹18.16b

55.1x

Ratio precio-beneficio (PE)

2.2x

Ratio precio-ventas (PS)

¿Está HIKAL sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de HIKAL
Ingresos	₹18.16b
Coste de los ingresos	₹9.23b
Beneficio bruto	₹8.93b
Otros gastos	₹8.21b
Beneficios	₹716.22m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)	5.81
Margen bruto	49.16%
Margen de beneficio neto	3.94%
Ratio deuda/patrimonio	67.5%

¿Cómo se ha desempeñado HIKAL a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

0.4%

Rentabilidad actual por dividendo

21%

Ratio de pagos

Resumen de acción HIKAL

Recompensas

Análisis de riesgos

Competidores de Hikal Limited

NSEI:SUPRIYA

₹29.3b

BSE:509079

₹29.7b

NSEI:INDOCO

₹30.5b

BSE:524348

₹45.6b

Historial de precios y rendimiento

Noticias y actualizaciones recientes

Hikal Limited (BSE:524735) agreed to acquire 5.73% stake in FPEL Ujwal Private Limited for INR 41.2 million.

Investor sentiment improves as stock rises 16%

Less than half of directors are independent

Hikal Limited Announces Appointment of Dharmesh Panchal as the Chief Technology Officer

Upcoming dividend of ₹0.60 per share at 0.4% yield

Dividend of ₹0.60 announced

Recent updates

Hikal Limited (BSE:524735) agreed to acquire 5.73% stake in FPEL Ujwal Private Limited for INR 41.2 million.

Investor sentiment improves as stock rises 16%

Less than half of directors are independent

Hikal Limited Announces Appointment of Dharmesh Panchal as the Chief Technology Officer

Upcoming dividend of ₹0.60 per share at 0.4% yield

Dividend of ₹0.60 announced

Third quarter 2024 earnings released: EPS: ₹1.31 (vs ₹2.14 in 3Q 2023)

Hikal Limited Declares Interim Dividend for the Financial Year 2023-2024, Payable on or Before March 9, 2024

Hikal Limited Announces Resignation of B. N. Kalyani as Director

Price target increased by 9.0% to ₹350

Second quarter 2024 earnings released: EPS: ₹1.02 (vs ₹2.01 in 2Q 2023)

Hikal Limited (BSE:524735) agreed to acquire 26% stake in Fpel Ujwal Private Limited for INR 41.2 million.

Price target increased by 10.0% to ₹353

Insufficient new directors

Hikal Limited Approves the Appointment of Berjis M Desai and V. Ramachandra Kaundinya as an Independent Director

Hikal Limited to Report Q2, 2024 Results on Nov 14, 2023

Hikal Limited, Annual General Meeting, Sep 26, 2023

Hikal Limited to Report Q1, 2024 Results on Aug 08, 2023

Hikal Limited Receives Communication from the Gujarat Pollution Control Board

A Look At The Fair Value Of Hikal Limited (NSE:HIKAL)

Hikal Limited Announces Recommendation of Final Dividend for the Financial Year 2022-23

Is Hikal (NSE:HIKAL) Using Too Much Debt?

Now 20% undervalued after recent price drop

Upcoming dividend of ₹0.60 per share at 0.5% yield

Hikal (NSE:HIKAL) Is Reducing Its Dividend To ₹0.60

Third quarter 2023 earnings released: EPS: ₹2.14 (vs ₹3.67 in 3Q 2022)

Hikal Limited Declares Interim Dividend for the Fiscal Year 2023, Payable on or Before March 3, 2023

Price target increased to ₹350

Investor sentiment improved over the past week

Founder & Executive Chairman recently bought ₹19m worth of stock

Hikal Limited (BSE:524735) acquired 26% stake in Radiance MH Sunrise Two Private Limited and Radiance MH Sunrise Four Private Limited for INR 46.2 million.

Investor sentiment improved over the past week

A Look At The Fair Value Of Hikal Limited (NSE:HIKAL)

Insufficient new directors

Second quarter 2023 earnings released: EPS: ₹2.01 (vs ₹3.57 in 2Q 2022)

Hikal Limited Approves Final Dividend for the Financial Year 2021-2022

Increases to CEO Compensation Might Be Put On Hold For Now at Hikal Limited (NSE:HIKAL)

Upcoming dividend of ₹0.40 per share

Insufficient new directors

Hikal Limited to Report Q3, 2023 Results on Feb 14, 2023

Investor sentiment improved over the past week

First quarter 2023 earnings released: ₹0.72 loss per share (vs ₹4.10 profit in 1Q 2022)

Hikal Limited to Report Q1, 2023 Results on Aug 10, 2022

Price target decreased to ₹416

Less than half of directors are independent

Hikal Limited Recommends Final Dividend

Hikal Limited to Report Q4, 2022 Results on May 28, 2022

Hikal Limited Announces Closure of Manufacturing Unit Located at MIDC Taloja, Dist. Raigad, Within 15 Days

Calculating The Fair Value Of Hikal Limited (NSE:HIKAL)

Hikal (NSE:HIKAL) Is Increasing Its Dividend To ₹1.20

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Hikal Limited Declares Interim Dividend for the Financial Year 2021-22, Payable on or Before March 15, 2022

Investor sentiment deteriorated over the past week

Is Hikal (NSE:HIKAL) Using Too Much Debt?

Less than half of directors are independent

Price target increased to ₹622

Investor sentiment improved over the past week

Investor sentiment improved over the past week

With EPS Growth And More, Hikal (NSE:HIKAL) Is Interesting